Clinical Trials Logo
  1. Home
  2. Early-Stage Breast Carcinoma
  3. NCT06387173
  4. Details
NCT06387173 Clinical Trial

Registry of Patients Undergoing Cryoablation for Early Stage Breast Cancer

Early Stage Breast Carcinoma Clinical Trial

Official title:
Registry of Patients Undergoing Cryoablation for Early Stage Breast Cancer

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT06387173
Other study ID # 23-001743
Secondary ID NCI-2024-01240
Status Recruiting
Phase
First received
Last updated
Start date January 4, 2024
Est. completion date January 3, 2099

Study information
Verified date February 2024
Source Jonsson Comprehensive Cancer Center
Contact Aletta Deranteriassian
Phone (310)206-6114
Email ADeranteriassian@mednet.ucla.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study evaluates the side effects and outcomes of patients who undergo cryoablation for early stage breast cancer.

Description:

PRIMARY OBJECTIVE: I. To obtain observational real-life data of patients who choose this non-conventional treatment and to follow their outcomes. OUTLINE: This is an observational study. Patients have their medical records reviewed on study.

Recruitment information / eligibility
Status Recruiting
Enrollment 100
Est. completion date January 3, 2099
Est. primary completion date January 3, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients undergoing cryoablation for breast cancer

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Non-Interventional Study
Non-interventional study

Locations
Country Name City State
United States UCLA / Jonsson Comprehensive Cancer Center Los Angeles California

Sponsors (1)
Lead Sponsor Collaborator
Jonsson Comprehensive Cancer Center

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Prospectively track patients who undergo cryoablation for breast cancer and record post-treatment related events. record follow up of symptoms, reported complications, breast imaging findings, and results of any future biopsies related to cancer, and treatment of breast cancer. five years from last participant enrollment
See also
  Status Clinical Trial Phase
Recruiting NCT05368428 - Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer N/A
Active, not recruiting NCT02212860 - Stereotactic Image-Guided Neoadjuvant Ablative Radiation Then Lumpectomy N/A
Active, not recruiting NCT02876640 - Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer Phase 1
Recruiting NCT05945290 - Pre-analytical Factors Affecting ctDNA Analysis in Early and Locally Advanced Breast Cancer
Active, not recruiting NCT02167490 - Sentinel Node Vs Observation After Axillary Ultra-souND N/A
Recruiting NCT02889874 - EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer N/A
Active, not recruiting NCT02095743 - Tolerance of PICC Line Versus Implanted Port for Adjuvant Chemotherapy in Early Breast Cancer Phase 2
Completed NCT03003611 - Observational Trial on the Impact of Hypnose Used as a Sedation in Oncology Surgery in Breast Cancer N/A
Recruiting NCT06113016 - Prevention of Frailty With Fisetin and Exercise (PROFFi) in Breast Cancer Survivors Phase 2
Recruiting NCT05417867 - Association Between Changes in the Gut Microbiome and Chemotherapy-Induced Nausea in Stage I-III Breast Cancer